Fundraising Fox
SeaStar Medical
NASDAQ: ICUDenver, US · Founded 2007 · Delaware corporation · 4 known investors
Find your way into SeaStar Medical
Sign up to see every warm intro you have to SeaStar Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SeaStar Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SeaStar Medical develops the Selective Cytopheretic Device (SCD), a therapy that targets highly activated neutrophils and monocytes to neutralize the hyperinflammatory immune response in critically ill ICU patients facing conditions such as infection, trauma, or surgery. The device integrates with existing hemodialysis delivery systems and is aimed at reducing dependency on dialysis and time in the ICU.
Founders & leadership
SeaStar Medical was founded in 2007 by H David Humes.
HD
H David HumesFounder
ES
Eric SchlorffChief Executive OfficerChief Executive Officer of SeaStar Medical, which develops the Selective Cytopheretic Device to address hyperinflammatory immune responses in critically ill patients. He has experience in healthcare venture capital relationships and executing public market transactions.
PD
Peter DeComoExecutive
MM
Mark MorsfieldCEO (CytoPherx)2007–2015Mark Morsfield is an executive officer at SeaStar Medical, which develops the Selective Cytopheretic Device to address hyperinflammatory immune responses in critically ill ICU patients. He has over 30 years of experience in life sciences, healthcare services, venture capital, and M&A, with involvement across seed-stage, growth, and commercialization phases.
RJ
R James DanehyExecutive
JB
Jen Baird, NACD.DCChair of the Board | Independent Board Director [Nasdaq: ICU]Jen Baird is board director at SeaStar Medical with over 35 years of experience, including two decades as a CEO of venture and angel-backed startups in healthcare where she raised over $75M and led product development and commercialization efforts resulting in FDA clearances and exits. She holds NACD Directorship Certification and serves on boards of public, private, and non-profit organizations.
MM
Michael MessingerChief Financial OfficerMichael Messinger is Chief Financial Officer at SeaStar Medical, which develops an immunomodulatory device for critically ill ICU patients. He has over 20 years of experience in biotechnology finance, including raising more than $275 million in capital and managing banking and investor relationships.
Board
AV
KV
Kenneth Van HeelBoard director
LB
Leslie BottorffBoard director
WW
William WhiteBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$21.7M disclosed across 2 rounds · 2011–2020
▶$5.3MraisedDec 2020 · 4 investors · Other Health CareRule 506(b)
▶$5.3MraisedDec 2020 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric SchlorffExecutive Officer, Director
- Amount sold
- $5.3M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.4MraisedJan 2012 · 23 investors · Other Health CareRule 506(b)
▶$16.4MraisedJan 2012 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alvin VitangcolDirector
- Kenneth Van HeelDirector
- Leslie BottorffDirector
- William WhiteDirector
- H David HumesDirector
- Peter DeComoDirector
- Mark MorsfieldExecutive Officer
- R James DanehyExecutive Officer, Director
- Offering amount
- $33.9M
- Amount sold
- $16.4M
- Minimum investment
- $12.5K
- First sale
- Sep 2011
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through SeaStar Medical went on to found or lead other companies.
Related companies · 7
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
TipRanksFinancial analysis and stock research platform.
TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Companies working in the same space as SeaStar Medical.
Frequently asked questions
- What does SeaStar Medical do?
- SeaStar Medical develops the Selective Cytopheretic Device (SCD), a therapy that targets highly activated neutrophils and monocytes to neutralize the hyperinflammatory immune response in critically ill ICU patients facing conditions such as infection, trauma, or surgery. The device integrates with existing hemodialysis delivery systems and is aimed at reducing dependency on dialysis and time in the ICU.
- Who founded SeaStar Medical?
- SeaStar Medical was founded by H David Humes in 2007.
- Who are SeaStar Medical's investors?
- SeaStar Medical's investors include Aphelion Capital, Capital Midwest Fund, Early Stage Partners, LP, WMU Biosciences Research & Commercialization Center.
- How much funding has SeaStar Medical raised?
- SeaStar Medical has disclosed $21.7M raised across 2 rounds.
- Where is SeaStar Medical headquartered?
- SeaStar Medical is headquartered in Denver, US.